Citation Impact
Citing Papers
Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
2011
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
2021 StandoutNobel
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
2020
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
2010
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
The molecular hallmarks of epigenetic control
2016 Standout
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
2014
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Animal models of human disease: zebrafish swim into view
2007 Standout
Acute lymphoblastic leukaemia
2008
Bortezomib‐induced apoptosis in mature T‐cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl‐1
2008
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
2004 StandoutNature
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Contribution of platelets to tumour metastasis
2011 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
NOTCH1-induced T-cell leukemia in transgenic zebrafish
2007
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Targeted therapy in rare cancers—adopting the orphans
2012
Hepatic oval ‘stem’ cell in liver regeneration
2002
Topoisomerase I-DNA Complexes Contribute to Arsenic Trioxide-induced Apoptosis
2004
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
2007
Antibody therapy of cancer
2012 Standout
Can the cardiomyocyte cell cycle be reprogrammed?
2007
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
2014
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
2015
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Platelets in inflammation and atherogenesis
2005 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Benefits of Metformin in Attenuating the Hallmarks of Aging
2020
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
2010
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
2017
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
2009 Standout
The PI3K Pathway in Human Disease
2017 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
2016
Histone methyltransferases in cancer
2009
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
CXCR3 ligands in disease and therapy
2014
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation
2010 StandoutNature
Oxidative stress and apoptosis: a new treatment paradigm in cancer
2006
Effect of Ions on the Structure of Water: Structure Making and Breaking
2009 Standout
A potential model for the study of ices and amorphous water: TIP4P/Ice
2005 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Structure and Nanostructure in Ionic Liquids
2015 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Water as an Active Constituent in Cell Biology
2007 Standout
Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis
2015
Photosensitizer Nanodot Eliciting Immunogenicity for Photo‐Immunologic Therapy of Postoperative Methicillin‐Resistant Staphylococcus aureus Infection and Secondary Recurrence
2021
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Multiple Sclerosis
2018 Standout
Water Stability and Adsorption in Metal–Organic Frameworks
2014 Standout
Unimpeded Permeation of Water Through Helium-Leak–Tight Graphene-Based Membranes
2012 StandoutScienceNobel
Structural Evidence for the Ordered Crystallites of Ionic Liquid in Confined Carbon Nanotubes
2009
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Cytokine Storm
2020 Standout
Transient Regenerative Potential of the Neonatal Mouse Heart
2011 StandoutScience
A general purpose model for the condensed phases of water: TIP4P/2005
2005 Standout
Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations
2008 Standout
The electronic structure of liquid water within density-functional theory
2005
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
2011
Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysis
2017
Cancer treatment and survivorship statistics, 2016
2016 Standout
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
2008
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
2008
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
2020
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Control of Cardiac Growth by Histone Acetylation/Deacetylation
2006
Unusual Hydrogen Bonding in Water-Filled Carbon Nanotubes
2006
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL
2008
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
2000
A reoptimization of the five-site water potential (TIP5P) for use with Ewald sums
2004
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
2017
Water in Nonpolar Confinement: From Nanotubes to Proteins and Beyond
2007
Increased mTOR activation in idiopathic multicentric Castleman disease
2020
Targeting the Human Genome–Microbiome Axis for Drug Discovery: Inspirations from Global Systems Biology and Traditional Chinese Medicine
2012
Works of Junmin Li being referenced
Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection
2020
Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma
2007
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells
2011
Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion
2013
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
2018
Arsenic Trioxide and Acute Promyelocytic Leukemia: Clinical and Biological
2007
HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells
2017
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B‐cell lymphoma patients who are HBsAg‐negative/ HBcAb‐positive: a multicenter retrospective study
2010
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor
2008
Platelet Factor 4 and Other CXC Chemokines Support the Survival of Normal Hematopoietic Cells and Reduce the Chemosensitivity of Cells to Cytotoxic Agents
1997
All-trans retinoic acid/As 2 O 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
2004
Ab initio studies of quasi-one-dimensional pentagon and hexagon ice nanotubes
2003
RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation
2011
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
2009
NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis
2006
Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy
1997
Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma
2017